C081 | OPTIMIZING MOLECULAR DIAGNOSIS OF SYSTEMIC MASTOCYTOSIS IN THE ERA OF KIT TYROSINE KINASE INHIBITORS: RESULTS OF A SURVEY AND OF A NATIONWIDE PROFICIENCY CONTROL ROUND OF KIT D816V MUTATION TESTING PROMOTED BY RIMA (RETE ITALIANA MASTOCITOSI)
Molecular testing plays a key role in the diagnosis and classification of SM and requires sensitive PCR-based methods, since disease burden, especially in the indolent forms, may be very low. The importance of reliable and accurate testing prompted RIMA to undertake, with the sponsorship of GIMEMA...
| Published in: | Haematologica |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-09-01
|
| Online Access: | https://haematologica.org/article/view/12845 |
